Free Trial
CVE:VM

Voyageur Pharmaceuticals (VM) Stock Price, News & Analysis

Voyageur Pharmaceuticals logo
C$0.16 -0.01 (-3.13%)
As of 09/12/2025 03:46 PM Eastern

About Voyageur Pharmaceuticals Stock (CVE:VM)

Key Stats

Today's Range
C$0.16
C$0.16
50-Day Range
C$0.16
C$0.29
52-Week Range
C$0.05
C$0.36
Volume
166,040 shs
Average Volume
193,238 shs
Market Capitalization
C$26.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Voyageur Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VM Stock News Headlines

Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel
See More Headlines

VM Stock Analysis - Frequently Asked Questions

Voyageur Pharmaceuticals' stock was trading at C$0.09 at the start of the year. Since then, VM stock has increased by 82.4% and is now trading at C$0.16.

Shares of VM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Voyageur Pharmaceuticals investors own include GFG Resources (GFG), Pine Cliff Energy (PNE), Tamarack Valley Energy (TVE), Caladrius Biosciences (CLBS), Capstone Copper (CS), Calibre Mining (CXB) and Mawson Gold (MAW).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
CVE:VM
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$1.66 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-117.77%
Return on Assets
-30.77%

Debt

Debt-to-Equity Ratio
4.23
Current Ratio
0.10
Quick Ratio
0.84

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$0.00 per share
Price / Cash Flow
35.00
Book Value
C$0.01 per share
Price / Book
22.88

Miscellaneous

Outstanding Shares
168,262,000
Free Float
N/A
Market Cap
C$26.08 million
Optionable
Not Optionable
Beta
-0.12
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (CVE:VM) was last updated on 9/13/2025 by MarketBeat.com Staff
From Our Partners